NCT01266174View on ClinicalTrials.gov

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

November 30, 2012

Conditions
Cognitive ImpairmentSchizophrenia
Interventions
DRUG

Eltoprazine

Comparison of eltoprazine, dosed orally, for 8 weeks

DRUG

Placebo

Placebo to match eltoprazine

Trial Locations (6)

10032

Research Foundation for Mental Hygiene, Inc., New York

21228

Maryland Psychiatric Research Center, Catonsville

27705

Duke University School of Medicine, Durham

60611

Northwestern University Feinberg School of Medicine, Chicago

90073

Veteran's Administration of Greater Los Angeles, Los Angeles

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Amarantus BioScience Holdings, Inc.

INDUSTRY

NCT01266174 - Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults | Biotech Hunter | Biotech Hunter